Intensive prehabilitation program for cancer surgery patients
STRONG for Surgery & Strong for Life - Against All Odds: Intensive Prehabilitation Including Smoking, Nutrition, Alcohol and Physical Activity for Risk Reduction in Cancer Surgery
This study tests whether a special program that helps cancer surgery patients improve their lifestyle habits can lower their surgical risks and lead to better recovery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Bispebjerg Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Copenhagen, Region H) |
| Trial ID | NCT04088968 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of intensive lifestyle interventions, focusing on smoking, nutrition, alcohol consumption, and physical activity (SNAP), in reducing surgical risks for patients undergoing urological cancer surgery. It includes three clinical intervention studies involving 100 patients who are screened for at least one SNAP factor. Participants will receive tailored educational sessions over six weeks, while control groups will receive standard care. The aim is to optimize individual risk factors and improve clinical outcomes post-surgery.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 scheduled for cystectomy due to bladder cancer and who have at least one identified SNAP factor.
Not a fit: Patients who are pregnant, breastfeeding, or have contraindications to exercise may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce postoperative complications and improve recovery for cancer surgery patients.
How similar studies have performed: Previous studies have shown promise in using lifestyle interventions to improve surgical outcomes, indicating that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients \> 18 years scheduled for cystectomy due to bladder cancer * Referral to neoadjuvant chemotherapy * Screened positive for minimum 1 SNAP factor * Signed informed consent Exclusion Criteria: * Pregnancy and breastfeeding * Allergy to pharmaceutical support (Nicotine Replacement Therapy, Disulfiram) * Contraindications to exercise.
Where this trial is running
Copenhagen, Region H
- Dept Urology 2112, Copenhagen University Hospital, Rigshospitalet — Copenhagen, Region H, Denmark (Recruiting)
Study contacts
- Principal investigator: Hanne Tonnesen, Professor MD — WHOCC, The Parker Institute, Bispebjerg-Frederiksberg Hospital, RegH, Copenhagen
- Study coordinator: Hanne Tønnesen, Professor MD
- Email: hanne.tonnesen@regionh.dk
- Phone: +4538163840
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.